NeuroPace Receives FDA Feedback on IGE PMA Supplement
MOUNTAIN VIEW, Calif., July 28, 2026 NeuroPace announced that the U.S. Food and Drug Administration (FDA) has informed the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MOUNTAIN VIEW, Calif., July 28, 2026 NeuroPace announced that the U.S. Food and Drug Administration (FDA) has informed the...
THE WOODLANDS, Texas, July 23, 2026 Autonomix Medical, Inc. announced that it has been granted U.S. Patent No. 12,471,776,...
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace One® Proactive Intelligence, a proprietary artificial intelligence (AI)...
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
MONTREAL, Canada / SEATTLE, Washington, July 12, 2026 HDT Bio Corp. has launched a major Canadian clinical development initiative...
TOKYO, Japan / CAMBRIDGE, Massachusetts, USA, July 12, 2026 Eisai Co., Ltd. and Biogen Inc. have announced new clinical...
BRIDGEWATER, New Jersey, USA / CAESAREA, Israel, July 9, 2026 Theranica has announced a major reimbursement milestone for Nerivio®,...
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
MINNEAPOLIS, Minn., July 1, 2026 Saluda Medical has achieved a major regulatory milestone with the U.S. Food and Drug...
ESPOO, Finland, June 30, 2026 Orion Pharma has announced a strategic agreement with Shilpa Biologicals Private Limited, a wholly...
